FDA
-
-
-
-
-
-
-
Curium to acquire Lantheus in deal valued at up to $8 billion
-
-
-
-
-
-
-
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year
-
-
-
-
-
-
-
Lantheus receives FDA approval for PYLARIFY TruVu prostate cancer imaging agent
-
-
-
-
-
-
-
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
-
-
-
-
-
-
-
Lantheus licenses prostate cancer imaging agent to GE HealthCare for Japan
-
-
-
-
-
-
-
Lantheus completes Life Molecular Imaging acquisition
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) Announces MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies
-
334,271 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


